260660 — Korea Arlico Pharm Co Cashflow Statement
0.000.00%
Last trade - 00:00
- KR₩76bn
- KR₩92bn
- KR₩187bn
- 40
- 57
- 11
- 24
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | ARS | ARS | Annual Audited Accounts |
Standards: | IFRS | IFRS | — | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 10,031 | 9,728 | 5,605 | 8,391 | 3,476 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 3,679 | 1,849 | 1,068 | 1,908 | -174 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -2,275 | -9,045 | -307 | -8,570 | -914 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 13,133 | 4,546 | 8,967 | 4,836 | 7,148 |
Capital Expenditures | -2,963 | -10,189 | -5,551 | -21,735 | -23,520 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 7,044 | 16,856 | -586 | 12,817 | -3,730 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 4,081 | 6,666 | -6,137 | -8,919 | -27,250 |
Financing Cash Flow Items | -3.51 | — | -56.3 | 19 | 0 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -7,479 | -17,737 | 1,151 | 18,055 | 15,758 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 9,724 | -6,535 | 4,013 | 13,876 | -4,329 |